Ardelyx Inc (NAS:ARDX)
$ 5.67 -0.02 (-0.35%) Market Cap: 1.34 Bil Enterprise Value: 1.26 Bil PE Ratio: 0 PB Ratio: 8.49 GF Score: 75/100

Ardelyx Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 12:30PM GMT
Release Date Price: $3.76 (+0.80%)
Dennis Ding
Jefferies - Analyst

Good morning. Welcome to the Jefferies 2023 Healthcare Conference. My name is Dennis Ding. I'm biotech analyst at Jefferies. And I had the pleasure of having the Ardelyx team here this morning to talk about all the great progress that they've made over the years.

I know it's been kind of a bumpy road over the last couple of years around XPHOZAH, but you guys have seemingly navigated that pretty well. And you guys have obviously some great updates throughout the year. And you guys are also launching an IBS drug as well.

So maybe before we really start, maybe you can just rightside us -- rightsize us in terms of your progress this year and where you see this year going.

Mike Raab
Ardelyx, Inc. - President & CEO

Dennis, thank you and the entire Jefferies team for having us here. Looking at where we have navigated over these last 12 months, and certainly even longer than that, is to be here, now with about a year of launch experience under our belts with Ibsrela when we had to pivot to it with the unexpected

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot